Transgenomic Sues Power3 for Libel, Slander, Breach of Contract in Protein Biomarker Deal | GenomeWeb

This story originally ran on Feb. 23.

Transgenomic this week sued Power3 Medical Products, alleging breach of contract over a deal to market Power3's biomarker tests for neurodegenerative diseases.

The suit, filed in the US District Court in Nebraska, also accused Power3 of slander and libel, and of making "false representations" about its tests in order to "induce" Transgenomic into its marketing agreement with Power3.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

DNA Sequencing is being used by researchers in California to survey fish and marine life as part of a conservation effort.

This week in Nature: Researchers describe the adaptation of organisms to environmental changes, while another study provides new insights into pig domestication.

The blog Sartorial Science seeks to challenge the stereotype of scientists as frumpy, messy, clueless dressers.

While one researcher says cloning the mammoth may be decades away, if successful, it may lead to a theme park of species that would no longer be extinct.